Trump Administration Waives Halt on Distribution of HIV Medications Via PEPFAR
However, the waiver does not address resumption of other PEPFAR services
Trump Pauses Disbursement of Global HIV Treatment Funds
PEPFAR could face a funding delay of as long as 180 days
Recommendations Provided for Treating, Preventing HIV
Antiretroviral therapy recommended for all individuals with HIV; recommendations provided for those with specific clinical circumstances
U.S. Health Care Spending Reached $4.9 Trillion in 2023
Health sector's share of the economy was similar in 2023 and 2022, but lower than in 2020 and 2021, during height of COVID-19
Prevalence of Cirrhosis Higher for Trans- Versus Cisgender Adults
Transgender adults with cirrhosis have higher proportions of anxiety, depression, HIV/AIDS
2000 to 2024 Saw Rise in Physician Union Petitions
Most organizing efforts motivated by nonfinancial factors
7.9 Percent of People of All Ages Uninsured in January to June 2024
No change seen in percentage of people who were uninsured from 2023 to first half of 2024; lower percentage had public coverage
Incidence of HIV Lower With Twice-Yearly Subcutaneous Lenacapavir
HIV incidence was significantly lower with lenacapavir than daily oral emtricitabine-tenofovir disoproxil fumarate
Preferential Promotion of White Men Persisting in Academic Medicine
Black women significantly less likely to be promoted to assistant professor, full professor compared with White men
Considerable Scale-Up Needed to Achieve 2025 Goals for HIV PrEP
About 3.5 million persons used PrEP in 2023 globally, which was far below the goal of 21.2 million set for 2025
